| Chelsea Elizabeth Donathan, DO | |
|
125 Diana Dr, Webster Springs, WV 26288-9078 | |
| (304) 847-5682 | |
| (304) 847-5982 |
| Full Name | Chelsea Elizabeth Donathan |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 125 Diana Dr, Webster Springs, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558867457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 3766 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Webster County Memorial Hospital | Webster springs, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Webster Memorial Hospital, Inc | 6709275373 | 9 |
News Archive
The American College of Physicians today - along with other health care organizations - submitted an amicus curiae (friend of the court) brief to the Supreme Court of the United States in the King v. Burwell case, urging the court to uphold the premium subsidies created by the Affordable Care Act in all states.
Global malaria elimination funding is declining at a time when it remains crucial to eliminating the disease worldwide, according to a study published in the open access Malaria Journal.
A scientific study indicates that the lives of 400 Swedes could be saved annually if measures were taken to prevent side effects of pharmaceuticals. Now these researchers in Sweden, at the Nordic School of Public Health (NHV) and elsewhere, have reviewed randomly selected deaths in three Swedish counties and found that 14 percent of these deaths could have been avoided if a drug had been replaced or if the dosage had been lowered.
Obstructive coronary artery disease (CAD) in women often presents with different types of symptoms than in men and can be challenging to diagnose due to a variety of factors. A national panel of experts convened to review the latest evidence regarding CAD in women, diagnostic approaches, and new types of tests and technologies.
Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization in less than one hour. The test runs on Cepheid's GeneXpert® System, the world's leading molecular platform for accuracy, speed, and ease-of-use.
› Verified 4 days ago
| Entity Name | Webster Memorial Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679241152 PECOS PAC ID: 6709275373 Enrollment ID: O20211227001169 |
News Archive
The American College of Physicians today - along with other health care organizations - submitted an amicus curiae (friend of the court) brief to the Supreme Court of the United States in the King v. Burwell case, urging the court to uphold the premium subsidies created by the Affordable Care Act in all states.
Global malaria elimination funding is declining at a time when it remains crucial to eliminating the disease worldwide, according to a study published in the open access Malaria Journal.
A scientific study indicates that the lives of 400 Swedes could be saved annually if measures were taken to prevent side effects of pharmaceuticals. Now these researchers in Sweden, at the Nordic School of Public Health (NHV) and elsewhere, have reviewed randomly selected deaths in three Swedish counties and found that 14 percent of these deaths could have been avoided if a drug had been replaced or if the dosage had been lowered.
Obstructive coronary artery disease (CAD) in women often presents with different types of symptoms than in men and can be challenging to diagnose due to a variety of factors. A national panel of experts convened to review the latest evidence regarding CAD in women, diagnostic approaches, and new types of tests and technologies.
Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization in less than one hour. The test runs on Cepheid's GeneXpert® System, the world's leading molecular platform for accuracy, speed, and ease-of-use.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chelsea Elizabeth Donathan, DO 125 Diana Dr, Webster Springs, WV 26288-9078 Ph: (304) 847-5382 | Chelsea Elizabeth Donathan, DO 125 Diana Dr, Webster Springs, WV 26288-9078 Ph: (304) 847-5682 |
News Archive
The American College of Physicians today - along with other health care organizations - submitted an amicus curiae (friend of the court) brief to the Supreme Court of the United States in the King v. Burwell case, urging the court to uphold the premium subsidies created by the Affordable Care Act in all states.
Global malaria elimination funding is declining at a time when it remains crucial to eliminating the disease worldwide, according to a study published in the open access Malaria Journal.
A scientific study indicates that the lives of 400 Swedes could be saved annually if measures were taken to prevent side effects of pharmaceuticals. Now these researchers in Sweden, at the Nordic School of Public Health (NHV) and elsewhere, have reviewed randomly selected deaths in three Swedish counties and found that 14 percent of these deaths could have been avoided if a drug had been replaced or if the dosage had been lowered.
Obstructive coronary artery disease (CAD) in women often presents with different types of symptoms than in men and can be challenging to diagnose due to a variety of factors. A national panel of experts convened to review the latest evidence regarding CAD in women, diagnostic approaches, and new types of tests and technologies.
Cepheid today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® SA Nasal Complete, the first and only molecular test designed for the simultaneous detection and differentiation of both Staphylococcus aureus (SA) and Methicillin-resistant Staphylococcus aureus (MRSA) colonization in less than one hour. The test runs on Cepheid's GeneXpert® System, the world's leading molecular platform for accuracy, speed, and ease-of-use.
› Verified 4 days ago
Steven W Craft, DO General Practice Medicare: Medicare Enrolled Practice Location: 324 Miller Mountain Dr, Webster Springs, WV 26288 Phone: 304-847-5682 Fax: 304-847-5985 | |
Dr. Vonda Lynn York-mcelwain, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 324 Miller Mountain Dr, Webster Springs, WV 26288 Phone: 304-847-5682 |